论文部分内容阅读
澳大利亚制药公司Novogen近日宣布，将开始抗癌药phenoxodiol口服制剂的临床研究。本品的静脉注射剂目前正在美国和澳大利亚进行治疗癌症的三项临床研究。本品属于新一代的信号转导抑制剂。这类药物通过对功能失常癌细胞的信号过程进行逆转，从而阻断癌症的进程。在这治疗过程?
Australian pharmaceutical company Novogen announced recently that it will begin a clinical study of an oral anticancer drug, phenoxodiol. Intravenous injections of this product are currently undergoing three clinical studies in the United States and Australia for the treatment of cancer. This product belongs to a new generation of signal transduction inhibitors. These drugs block the cancer process by reversing the signaling process in dysfunctional cancer cells. In this treatment process?